{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:02:11Z","timestamp":1789970531053,"version":"4.0.1"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Infantile bullous pemphigoid (IBP) is a rare autoimmune bullous skin disease that occurs in infants, for which standardized targeted therapeutic regimens remain unavailable. Herein, we report two infants with IBP treated with nicotinamide monotherapy. Complete clinical remission was observed within 3 weeks and 10 days after treatment initiation, respectively. Following clinical improvement, nicotinamide was gradually tapered and discontinued in approximately 2 months. No recurrence was observed during long-term follow-up. However, given the limited number of cases, these observations do not establish the therapeutic efficacy of nicotinamide but provide clinical experience with nicotinamide monotherapy in IBP.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1935375","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:35:37Z","timestamp":1789968937000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Nicotinamide monotherapy for infantile bullous pemphigoid with long-term follow-up"],"prefix":"10.3389","volume":"17","author":[{"given":"Peng","family":"Qu","sequence":"first","affiliation":[{"name":"Dermatology Hospital of Shandong First Medical University","place":["Jinan, Shandong, China"]},{"name":"Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guizhi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Dermatology Hospital of Shandong First Medical University","place":["Jinan, Shandong, China"]},{"name":"Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoqi","family":"Yang","sequence":"additional","affiliation":[{"name":"Dermatology Hospital of Shandong First Medical University","place":["Jinan, Shandong, China"]},{"name":"Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-014-0185-6","article-title":"Bullous pemphigoid in infants: characteristics, diagnosis and treatment","volume":"9","author":"Schwieger-Briel","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.70308","article-title":"European S2k guidelines on management of autoimmune blistering diseases in children and adolescents","volume":"40","author":"Nanda","year":"2026","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2018.3383","article-title":"Infantile bullous pemphigoid following vaccination","volume":"28","author":"Guerra","year":"2018","journal-title":"Eur J Dermatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15440","article-title":"Infantile bullous pemphigoid after meningococcal B vaccine","volume":"60","author":"P\u00e9rez-Feal","year":"2021","journal-title":"Int J Dermatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12231","article-title":"Postvaccination bullous pemphigoid in infancy: report of three new cases and literature review","volume":"30","author":"de la Fuente","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jdrv.2024.11.004","article-title":"Insights into bullous pemphigoid: A comprehensive review of diagnostic modalities","volume":"3","author":"Obijiofor","year":"2025","journal-title":"JAAD Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2025.2465405","article-title":"Diagnostic methods and strategies for autoimmune bullous diseases","volume":"21","author":"Qian","year":"2025","journal-title":"Expert Rev Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12892","article-title":"Childhood linear IgA bullous dermatosis successfully treated with oral nicotinamide","volume":"41","author":"Cui","year":"2016","journal-title":"Clin Exp Dermatol"},{"key":"B9","article-title":"Tetracycline and nicotinamide for the treatment of bullous pemphigoid: our experience in Singapore","volume":"41","author":"Goon","year":"2000","journal-title":"Singapore Med J"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04835.x","article-title":"Guidelines for the management of bullous pemphigoid","volume":"147","author":"Wojnarowska","year":"2002","journal-title":"Br J Dermatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12072","article-title":"British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012","volume":"167","author":"Venning","year":"2012","journal-title":"Br J Dermatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002292.pub4","article-title":"Interventions for bullous pemphigoid","volume":"2023","author":"Singh","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"B13","first-page":"5","article-title":"The mechanisms of action of nicotinamide and zinc in inflammatory skin disease","volume":"77","author":"Fivenson","year":"2006","journal-title":"Cutis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2016.2909","article-title":"Bullous pemphigoid in infancy with spontaneous remission","volume":"27","author":"Nomura","year":"2017","journal-title":"Eur J Dermatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.08.005","article-title":"Infantile bullous pemphigoid treated with intravenous immunoglobulin therapy","volume":"57","author":"Sugawara","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12635","article-title":"Infantile bullous pemphigoid treated using intravenous immunoglobulin: case report and review of the literature","volume":"32","author":"Tekin","year":"2015","journal-title":"Pediatr Dermatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2022.09.003","article-title":"Recalcitrant infantile bullous pemphigoid successfully treated with cyclosporine","volume":"29","author":"Bar-Ilan","year":"2022","journal-title":"JAAD Case Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.14345","article-title":"Successful treatment of infantile refractory bullous pemphigoid with baricitinib","volume":"65","author":"Zhou","year":"2024","journal-title":"Australas J Dermatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1935375\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:35:40Z","timestamp":1789968940000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1935375\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":18,"alternative-id":["10.3389\/fimmu.2026.1935375"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1935375","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"article-number":"1935375"}}